Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read MoreNvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read MorePharmaceutical company AstraZeneca is planning to increase its total revenue by 75% and release 20 new medicines by 2030, including
Read MoreAmgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are progressing on their own treatments. Source link
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreAmgen's update fueled concerns about potential new competition in the weight loss drug market, sending shares of Novo Nordisk and
Read MoreAmgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli
Read MoreHere are the most important news items that investors need to start their trading day. Source link
Read MoreAmgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after
Read MoreHere are the S&P 500's most overbought and oversold names, which include Tesla. Source link
Read More